• Measure Summary
  • NQMC:009930
  • 2014 Nov
  • NQF-Endorsed Measure

Immunizations for adolescents: percentage of adolescents 13 years of age who had one dose of meningococcal vaccine and one tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap) or one tetanus, diphtheria toxoids vaccine (Td) by their 13th birthday.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010790
  • 2016 Jul
  • NQF-Endorsed Measure

Hospital-based inpatient psychiatric services: the total number of hours that all patients admitted to a hospital-based inpatient psychiatric setting were maintained in physical restraint.

The Joint Commission

  • Measure Summary
  • NQMC:008296
  • 2013 Jan

Chronic obstructive pulmonary disease (COPD): proportion of outpatients with COPD and a Medical Research Council (MRC) level of more than 3 who are offered participation in pulmonary rehabilitation at least once every three years.

Competence Centre for Clinical Quality and Health Informatics West; The Danish registry for Chronic Obstructive Pulmonary Disease

  • Measure Summary
  • NQMC:010540
  • 2015 Oct

Adherence to antipsychotic medications for individuals with schizophrenia: percentage of members 19 to 64 years of age during the measurement year with schizophrenia who were dispensed and remained on an antipsychotic medication for at least 80 percent of their treatment period.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010560
  • 2015 Oct
  • NQF-Endorsed Measure

Osteoporosis testing in older women: the percentage of Medicare women 65 to 85 years of age who report ever having received a bone density test to check for osteoporosis.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009961
  • 2014 Nov

Potentially harmful drug-disease interactions in the elderly: percentage of Medicare patients 65 years of age and older who have evidence of an underlying disease, condition or health concern and who were dispensed an ambulatory prescription for a potentially harmful medication, concurrent with or after the diagnosis.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010141
  • 2015 Oct
  • NQF-Endorsed Measure

Tobacco treatment: percent of patients who received counseling AND medication as well as those who received counseling and had reason for not receiving the medication during the hospital stay within the first three days after admission.

The Joint Commission

  • Measure Summary
  • NQMC:010528
  • 2015 Oct

Statin therapy for patients with diabetes: percentage of members 40 to 75 years of age during the measurement year with diabetes who do not have ASCVD who remained on a statin medication of any intensity for at least 80% of the treatment period.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010147
  • 2015 Oct
  • NQF-Endorsed Measure

Substance use: percent of patients who screened positive for unhealthy alcohol use who received the brief intervention during the hospital stay.

The Joint Commission

  • Measure Summary
  • NQMC:009257
  • 2015 Jul

Drug-drug interactions: percentage of patients who received a prescription for a target medication during the measurement period and who were dispensed a concurrent prescription for a precipitant medication.

Pharmacy Quality Alliance

  • Measure Summary
  • NQMC:010793
  • 2016 Jul
  • NQF-Endorsed Measure

Perinatal care: percentage of patients with elective vaginal deliveries or elective cesarean births at greater than or equal to 37 and less than 39 weeks of gestation completed.

The Joint Commission

  • Measure Summary
  • NQMC:009944
  • 2014 Nov
  • NQF-Endorsed Measure

Comprehensive adult diabetes care: percentage of patients 18 to 75 years of age with type 1 or type 2 diabetes who had an eye exam (retinal) performed.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010125
  • 2015 Oct

Venous thromboembolism (VTE): percent of patients diagnosed with confirmed VTE that are discharged to home, home care, court/law enforcement or home on hospice care on warfarin with written discharge instructions that address all four criteria: compliance issues, dietary advice, follow-up monitoring, and information about the potential for adverse drug reactions/interactions.

The Joint Commission

  • Measure Summary
  • NQMC:008299
  • 2013 Jan

Chronic obstructive pulmonary disease (COPD): proportion of outpatients with COPD receiving inhalation therapy who have their inhaler technique checked at least once a year.

Competence Centre for Clinical Quality and Health Informatics West; The Danish registry for Chronic Obstructive Pulmonary Disease

  • Measure Summary
  • NQMC:010542
  • 2015 Oct
  • NQF-Endorsed Measure

Annual monitoring for patients on persistent medications: percentage of members 18 years of age and older who received at least 180 treatment days of ambulatory medication therapy for a select therapeutic agent during the measurement year and at least one therapeutic monitoring event for the therapeutic agent in the measurement year.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010525
  • 2015 Oct
  • NQF-Endorsed Measure

Comprehensive diabetes care: percentage of members 18 to 75 years of age with diabetes (type 1 and type 2) who received medical attention for nephropathy.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010127
  • 2015 Oct
  • NQF-Endorsed Measure

Stroke: percent of ischemic and hemorrhagic stroke patients who received VTE prophylaxis or who have documentation why no VTE prophylaxis was given the day of or the day after hospital admission.

The Joint Commission

  • Measure Summary
  • NQMC:009947
  • 2014 Nov
  • NQF-Endorsed Measure

Comprehensive adult diabetes care: percentage of patients 18 to 75 years of age with type 1 or type 2 diabetes who had a foot exam (visual inspection, a sensory exam with monofilament and a pulse exam) during the measurement year.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010517
  • 2015 Oct
  • NQF-Endorsed Measure

Persistence of beta-blocker treatment after a heart attack: percentage of members 18 years of age and older during the measurement year who were hospitalized and discharged from July 1 of the year prior to the measurement year to June 30 of the measurement year with a diagnosis of AMI and who received persistent beta-blocker treatment for six months after discharge.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010511
  • 2015 Oct

Pharmacotherapy management of COPD exacerbation: percentage of COPD exacerbations for members 40 years of age and older who had an acute inpatient discharge or ED visit on or between January 1 and November 30 of the measurement year and who were dispensed a systemic corticosteroid within 14 days of the event.

National Committee for Quality Assurance